Guerbet S. A. (GBT) - Total Liabilities
Based on the latest financial reports, Guerbet S. A. (GBT) has total liabilities worth €669.94 Million EUR (≈ $783.23 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Guerbet S. A. - Total Liabilities Trend (2004–2025)
This chart illustrates how Guerbet S. A.'s total liabilities have evolved over time, based on quarterly financial data. See GBT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Guerbet S. A. Competitors by Total Liabilities
The table below lists competitors of Guerbet S. A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Baozun Inc
F:2BZA
|
Germany | €4.20 Billion |
|
Chialin Precision Industrial Co Ltd
TWO:3310
|
Taiwan | NT$4.18 Billion |
|
Chongkundang
KO:001630
|
Korea | ₩755.22 Billion |
|
InflaRx N.V
F:IF0
|
Germany | €13.66 Million |
|
Wintermar Offshore Marine Tbk
JK:WINS
|
Indonesia | Rp843.34 Billion |
|
Orion Gold NL
JSE:ORN
|
South Africa | ZAC43.66 Million |
|
CB Industrial Product Holding
KLSE:7076
|
Malaysia | RM217.44 Million |
|
Leo Systems
TWO:5410
|
Taiwan | NT$2.46 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Guerbet S. A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GBT market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guerbet S. A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guerbet S. A. (2004–2025)
The table below shows the annual total liabilities of Guerbet S. A. from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €669.94 Million ≈ $783.23 Million |
+3.76% |
| 2024-12-31 | €645.68 Million ≈ $754.87 Million |
-0.20% |
| 2023-12-31 | €646.97 Million ≈ $756.38 Million |
+15.52% |
| 2022-12-31 | €560.07 Million ≈ $654.78 Million |
-5.99% |
| 2021-12-31 | €595.74 Million ≈ $696.48 Million |
+3.08% |
| 2020-12-31 | €577.95 Million ≈ $675.69 Million |
-6.73% |
| 2019-12-31 | €619.68 Million ≈ $724.47 Million |
-13.22% |
| 2018-12-31 | €714.05 Million ≈ $834.80 Million |
+16.78% |
| 2017-12-31 | €611.45 Million ≈ $714.85 Million |
-14.28% |
| 2016-12-31 | €713.35 Million ≈ $833.98 Million |
+15.05% |
| 2015-12-31 | €620.06 Million ≈ $724.91 Million |
+186.36% |
| 2014-12-31 | €216.53 Million ≈ $253.15 Million |
-2.15% |
| 2013-12-31 | €221.29 Million ≈ $258.72 Million |
-5.73% |
| 2012-12-31 | €234.76 Million ≈ $274.46 Million |
-0.07% |
| 2011-12-31 | €234.92 Million ≈ $274.65 Million |
+11.08% |
| 2010-12-31 | €211.49 Million ≈ $247.26 Million |
+11.89% |
| 2009-12-31 | €189.01 Million ≈ $220.98 Million |
-4.17% |
| 2008-12-31 | €197.23 Million ≈ $230.58 Million |
+5.89% |
| 2007-12-31 | €186.26 Million ≈ $217.75 Million |
+6.81% |
| 2006-12-31 | €174.37 Million ≈ $203.86 Million |
+12.75% |
| 2005-12-31 | €154.65 Million ≈ $180.81 Million |
+14.17% |
| 2004-12-31 | €135.46 Million ≈ $158.37 Million |
-- |
About Guerbet S. A.
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconne… Read more